Potential therapeutic targets shared between leishmaniasis and cancer
S Rashidi, C Fernández-Rubio, R Manzano-Román… - Parasitology, 2021 - cambridge.org
The association of leishmaniasis and malignancies in human and animal models has been
highlighted in recent years. The misdiagnosis of coexistence of leishmaniasis and cancer …
highlighted in recent years. The misdiagnosis of coexistence of leishmaniasis and cancer …
[HTML][HTML] The potential role of Nrf2 signaling in Leishmania infection outcomes
AC Vivarini, UG Lopes - Frontiers in Cellular and Infection …, 2020 - frontiersin.org
Nrf2 [nuclear factor erythroid 2-related factor 2 (Nrf2)] regulates the expression of a plethora
of genes involved in the response to oxidative stress due to inflammation, aging, and tissue …
of genes involved in the response to oxidative stress due to inflammation, aging, and tissue …
Leishmaniasis and malignancy: A review and perspective
MAN Al-Kamel - Clinical Skin Cancer, 2017 - Elsevier
Leishmaniasis, a widely prevalent disease throughout tropical and subtropical regions of the
world, is a chronic protozoan infection of humans and mammals that remains grossly …
world, is a chronic protozoan infection of humans and mammals that remains grossly …
[HTML][HTML] Clonality testing in the lymph nodes from dogs with lymphadenomegaly due to Leishmania infantum infection
A Melendez-Lazo, AK Jasensky, IT Jolly-Frahija… - Plos one, 2019 - journals.plos.org
Introduction In southern European countries, multicentric lymphoma and leishmaniosis are
the main differential diagnoses in dogs presented with generalized lymphadenomegaly. The …
the main differential diagnoses in dogs presented with generalized lymphadenomegaly. The …
[HTML][HTML] Case report: Combination therapy with liposomal amphotericin B, N-methyl meglumine antimoniate, and pentamidine isethionate for disseminated visceral …
HT Vechi, ASV de Sousa, MA da Cunha… - The American Journal …, 2020 - ncbi.nlm.nih.gov
In immunocompromised patients, visceral leishmaniasis (VL) can present with atypical
clinical symptoms that include poor response to treatment. No optimal therapeutic regimen is …
clinical symptoms that include poor response to treatment. No optimal therapeutic regimen is …
[PDF][PDF] Doenças parasitárias como fatores de risco para o desenvolvimento de câncer
BJ Mano-Sousa, LMS Gomes, H Busatti - Rev. Med. Minas Gerais, 2019 - academia.edu
O câncer é um importante problema de saúde pública com distribuição mundial. Embora
pouco se saiba sobre a causa específica dos tumores, os fatores de risco são bem …
pouco se saiba sobre a causa específica dos tumores, os fatores de risco são bem …
Plasmacytoid dendritic cell and CD4+ T cell deficiencies in untreated Hodgkin disease: implications for susceptibility to opportunistic infections
M Shodell, S Kempin, FP Siegal - Leukemia & Lymphoma, 2014 - Taylor & Francis
Hodgkin disease (HD), usually a malignancy of early B cells [1], is associated with an
increased risk of opportunistic infections (OIs)[2–7]. Previous studies of infectious …
increased risk of opportunistic infections (OIs)[2–7]. Previous studies of infectious …
Visceral leishmaniasis concurrent with splenic marginal zone B-cell lymphoma
UL Julhakyan, AU Magomedova, VN Dvirnyk… - Terapevticheskii …, 2016 - ter-arkhiv.ru
Splenic marginal zone B-cell lymphoma (SMZBCL) is a rare non-Hodgkin B-cell lymphoma
that presents with morphologically mature lymphoid cells corresponding in their …
that presents with morphologically mature lymphoid cells corresponding in their …
[PDF][PDF] Kala-azar presenting as isolated cervical lymphadenopathy in an HIV-infected child
M Nandi, S Sarkar, R Mondal - South African Journal of Child Health, 2012 - ajol.info
Kala-azar presenting as isolated cervical lymphadenopathy in an HIV-infected child Page 1 88
SAJCH AUGUST 2012 Vol. 6 No. 3 S A J ournal of Child He alth CASE REPORT Kala-azar …
SAJCH AUGUST 2012 Vol. 6 No. 3 S A J ournal of Child He alth CASE REPORT Kala-azar …
[HTML][HTML] Сочетание висцерального лейшманиоза и селезеночной В-клеточной лимфомы из клеток маргинальной зоны
УЛ Джулакян, АУ Магомедова, ВН Двирнык… - Терапевтический …, 2016 - cyberleninka.ru
Селезеночная В-клеточная лимфома из клеток маргинальной зоны (СЛКМЗ)—редкая В-
клеточная неходжкинская лимфома (НХЛ), которая представлена морфологически …
клеточная неходжкинская лимфома (НХЛ), которая представлена морфологически …